165 related articles for article (PubMed ID: 35242698)
1. Cetuximab Combined With Sonodynamic Therapy Achieves Dual-Modal Image Monitoring for the Treatment of EGFR-Sensitive Non-Small-Cell Lung Cancer.
Qiu G; Xue L; Zhu X; Lu X; Liu L; Wang Z; Li X; Huang C; Liu J
Front Oncol; 2022; 12():756489. PubMed ID: 35242698
[TBL] [Abstract][Full Text] [Related]
2. Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy.
Iida M; Brand TM; Starr MM; Huppert EJ; Luthar N; Bahrar H; Coan JP; Pearson HE; Salgia R; Wheeler DL
Mol Cancer; 2014 Oct; 13():242. PubMed ID: 25344208
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria-Targeted and Ultrasound-Activated Nanodroplets for Enhanced Deep-Penetration Sonodynamic Cancer Therapy.
Zhang L; Yi H; Song J; Huang J; Yang K; Tan B; Wang D; Yang N; Wang Z; Li X
ACS Appl Mater Interfaces; 2019 Mar; 11(9):9355-9366. PubMed ID: 30734551
[TBL] [Abstract][Full Text] [Related]
4. MnO
Xu Y; Tan W; Chen M; Chen S; Tang K; Liao H; Niu C
Front Bioeng Biotechnol; 2022; 10():955127. PubMed ID: 36338124
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional nanozyme for multimodal imaging-guided enhanced sonodynamic therapy by regulating the tumor microenvironment.
Liu S; Zhang W; Chen Q; Hou J; Wang J; Zhong Y; Wang X; Jiang W; Ran H; Guo D
Nanoscale; 2021 Sep; 13(33):14049-14066. PubMed ID: 34477686
[TBL] [Abstract][Full Text] [Related]
6. Multi-Modal Imaging Monitored M2 Macrophage Targeting Sono-Responsive Nanoparticles to Combat MRSA Deep Infections.
Chen S; Wang J; Tang K; Liao H; Xu Y; Wang L; Niu C
Int J Nanomedicine; 2022; 17():4525-4546. PubMed ID: 36193213
[TBL] [Abstract][Full Text] [Related]
7. Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab.
Chen G; Kronenberger P; Teugels E; Umelo IA; De Grève J
BMC Med; 2012 Mar; 10():28. PubMed ID: 22436374
[TBL] [Abstract][Full Text] [Related]
8. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.
Raben D; Helfrich B; Chan DC; Ciardiello F; Zhao L; Franklin W; Barón AE; Zeng C; Johnson TK; Bunn PA
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):795-805. PubMed ID: 15701870
[TBL] [Abstract][Full Text] [Related]
9. Dual-sonosensitizer loaded phase-transition nanoparticles with tumor-targeting for synergistically enhanced sonodynamic therapy.
Li Q; Lin X; Fan Y; Rao M; Wang Y; Wang M; Wang Z; Hao L; Yuan G
Biomater Sci; 2021 Sep; 9(18):6126-6141. PubMed ID: 34378578
[TBL] [Abstract][Full Text] [Related]
10. Dual-targeting of EGFR and Neuropilin-1 attenuates resistance to EGFR-targeted antibody therapy in KRAS-mutant non-small cell lung cancer.
Kim YJ; Baek DS; Lee S; Park D; Kang HN; Cho BC; Kim YS
Cancer Lett; 2019 Dec; 466():23-34. PubMed ID: 31521695
[TBL] [Abstract][Full Text] [Related]
11. 'Mito-Bomb': a novel mitochondria-targeting nanosystem for ferroptosis-boosted sonodynamic antitumor therapy.
Wang J; Zhao Z; Liu Y; Cao X; Li F; Ran H; Cao Y; Wu C
Drug Deliv; 2022 Dec; 29(1):3111-3122. PubMed ID: 36131565
[TBL] [Abstract][Full Text] [Related]
12. Antibody conjugated PLGA nanoparticles for targeted delivery of paclitaxel palmitate: efficacy and biofate in a lung cancer mouse model.
Karra N; Nassar T; Ripin AN; Schwob O; Borlak J; Benita S
Small; 2013 Dec; 9(24):4221-36. PubMed ID: 23873835
[TBL] [Abstract][Full Text] [Related]
13. Sym004, a novel EGFR antibody mixture, can overcome acquired resistance to cetuximab.
Iida M; Brand TM; Starr MM; Li C; Huppert EJ; Luthar N; Pedersen MW; Horak ID; Kragh M; Wheeler DL
Neoplasia; 2013 Oct; 15(10):1196-206. PubMed ID: 24204198
[TBL] [Abstract][Full Text] [Related]
14. Modulation of Tumor Hypoxia by pH-Responsive Liposomes to Inhibit Mitochondrial Respiration for Enhancing Sonodynamic Therapy.
Zhang N; Tan Y; Yan L; Zhang C; Xu M; Guo H; Zhuang B; Zhou L; Xie X
Int J Nanomedicine; 2020; 15():5687-5700. PubMed ID: 32821097
[TBL] [Abstract][Full Text] [Related]
15. Immuno-PET imaging for non-invasive assessment of cetuximab accumulation in non-small cell lung cancer.
Yamaguchi A; Achmad A; Hanaoka H; Heryanto YD; Bhattarai A; Ratianto ; Khongorzul E; Shintawati R; Kartamihardja AAP; Kanai A; Sugo Y; S Ishioka N; Higuchi T; Tsushima Y
BMC Cancer; 2019 Oct; 19(1):1000. PubMed ID: 31651282
[TBL] [Abstract][Full Text] [Related]
16. Preparation of multifunctional nanobubbles and their application in bimodal imaging and targeted combination therapy of early pancreatic cancer.
Yang H; Zhao P; Zhou Y; Li Q; Cai W; Zhao Z; Shen J; Yao K; Duan Y
Sci Rep; 2021 Mar; 11(1):6254. PubMed ID: 33737559
[TBL] [Abstract][Full Text] [Related]
17. ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models.
Kang HN; Kim SH; Yun MR; Kim HR; Lim SM; Kim MS; Hong KW; Kim SM; Kim H; Pyo KH; Park HJ; Han JY; Youn HA; Chang KH; Cho BC
Lung Cancer; 2016 May; 95():57-64. PubMed ID: 27040853
[TBL] [Abstract][Full Text] [Related]
18. [Cetuximab in combination with icotinib overcomes the acquired resistance caused by EGFR T790M mutation in non-small cell lung cancer].
Wang M; Zhang L; Zhao X; Liu J; Chen Y; Wang C
Zhonghua Zhong Liu Za Zhi; 2014 Sep; 36(9):651-6. PubMed ID: 25564053
[TBL] [Abstract][Full Text] [Related]
19. Tumor growth inhibition with cetuximab and chemotherapy in non-small cell lung cancer xenografts expressing wild-type and mutated epidermal growth factor receptor.
Steiner P; Joynes C; Bassi R; Wang S; Tonra JR; Hadari YR; Hicklin DJ
Clin Cancer Res; 2007 Mar; 13(5):1540-51. PubMed ID: 17332300
[TBL] [Abstract][Full Text] [Related]
20. Mitochondria-targeted high-load sound-sensitive micelles for sonodynamic therapy to treat triple-negative breast cancer and inhibit metastasis.
Han X; Song Z; Zhou Y; Zhang Y; Deng Y; Qin J; Zhang T; Jiang Z
Mater Sci Eng C Mater Biol Appl; 2021 May; 124():112054. PubMed ID: 33947548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
